Therefore, pre-vaccination treatment with gemcitabine, which reduced DC-IL-10+generation, led to a stronger priming of antitumor immunity, and concomitant superior therapeutic efficacy in tumor bearing mice. The gene discussed is IL10; the disease is neoplasm.